Literature DB >> 8293860

Plasma lactate concentration in obesity and type 2 diabetes.

Y D Chen1, B B Varasteh, G M Reaven.   

Abstract

The purpose of this study was three-fold: 1) to define the effects of obesity and Type 2 diabetes on plasma lactate concentrations; 2) to relate changes in plasma lactate concentration to plasma glucose and insulin concentrations; and 3) to evaluate the effect of differences in blood sample processing on plasma lactate determination in a disparate population group. To accomplish this, fasting plasma lactate concentrations were determined in 30 volunteers (10 non-obese individuals with normal glucose tolerance, 10 obese individuals with Type 2 diabetes) on blood drawn, processed, and maintained in a variety of ways. Results demonstrated that fasting plasma lactate measurements were least confounded when blood was drawn without the subject "hand pumping" following venous occlusion, the samples maintained on ice at 4 degrees C until precipitated with perchloric acid, and kept as this temperature until lactate concentration was determined. Under these conditions, plasma lactate concentration was lowest in the non-obese group with normal glucose tolerance (0.81 +/- 0.07 mmol/L), highest in the obese subjects with Type 2 diabetes (1.46 +/- 0.14 mmol/L), and intermediate in obese individuals with normal glucose tolerance (1.17 +/- 0.13 mmol/L). All three groups were significantly different from each other. In addition plasma lactate concentrations were associated with both fasting plasma glucose and glycated haemoglobin concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8293860

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  26 in total

1.  Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study.

Authors:  Stephen P Juraschek; Elizabeth Selvin; Edgar R Miller; Frederick L Brancati; J Hunter Young
Journal:  Ann Epidemiol       Date:  2013-10-05       Impact factor: 3.797

2.  Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse.

Authors:  S Muñoz; S Franckhauser; I Elias; T Ferré; A Hidalgo; A M Monteys; M Molas; S Cerdán; A Pujol; J Ruberte; F Bosch
Journal:  Diabetologia       Date:  2010-07-10       Impact factor: 10.122

Review 3.  Update on the pathophysiology and management of uric acid renal stones.

Authors:  Jon-Emile S Kenny; David S Goldfarb
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

4.  Plasma lactate as a marker of metabolic health: Implications of elevated lactate for impairment of aerobic metabolism in the metabolic syndrome.

Authors:  Terry E Jones; Walter J Pories; Joseph A Houmard; Charles J Tanner; Donghai Zheng; Kai Zou; Paul M Coen; Bret H Goodpaster; William E Kraus; G Lynis Dohm
Journal:  Surgery       Date:  2019-06-25       Impact factor: 3.982

5.  Obesity, Anion Accumulation, and Anion Gap Metabolic Acidosis: A Cohort Study.

Authors:  Douglas C Lambert; Matthew K Abramowitz
Journal:  Kidney360       Date:  2021-09-09

6.  Molecular hydrogen affects body composition, metabolic profiles, and mitochondrial function in middle-aged overweight women.

Authors:  D Korovljev; T Trivic; P Drid; S M Ostojic
Journal:  Ir J Med Sci       Date:  2017-05-30       Impact factor: 1.568

7.  Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study.

Authors:  Stephen O Crawford; Ron C Hoogeveen; Frederick L Brancati; Brad C Astor; Christie M Ballantyne; Maria Inês Schmidt; Jeffery Hunter Young
Journal:  Int J Epidemiol       Date:  2010-08-25       Impact factor: 7.196

8.  Effects of strength training on muscle lactate release and MCT1 and MCT4 content in healthy and type 2 diabetic humans.

Authors:  Carsten Juel; Mads K Holten; Flemming Dela
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

9.  Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study.

Authors:  Stephen P Juraschek; Ghanshyam Palamaner Subash Shantha; Audrey Y Chu; Edgar R Miller; Eliseo Guallar; Ron C Hoogeveen; Christie M Ballantyne; Frederick L Brancati; Maria Inês Schmidt; James S Pankow; J Hunter Young
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Deletion of the diabetes candidate gene Slc16a13 in mice attenuates diet-induced ectopic lipid accumulation and insulin resistance.

Authors:  Tina Schumann; Jörg König; Christian von Loeffelholz; Daniel F Vatner; Dongyan Zhang; Rachel J Perry; Michel Bernier; Jason Chami; Christine Henke; Anica Kurzbach; Nermeen N El-Agroudy; Diana M Willmes; Dominik Pesta; Rafael de Cabo; John F O Sullivan; Eric Simon; Gerald I Shulman; Bradford S Hamilton; Andreas L Birkenfeld
Journal:  Commun Biol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.